Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and slows tumour growth in ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine, a ...

Pivotal study in MG met primary endpoint of change from baseline in MG-ADL in AChR+ population at 12 weeks, with a 5.6 point improvement in the higher dose arm (with 74% mean IgG reduction) and a 4.7 ...

Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...

This phenomenon leads to the production of an excessive amount of another antibody, immunoglobulin G (IgG). Under normal conditions, "vaccines generate a response through pneumococcus-specific IgG ...

Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...